Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
33,700
+50 (0.15%)
At close: Jul 17, 2025, 3:30 PM KST
19.08%
Market Cap193.45B
Revenue (ttm)205.07B
Net Income (ttm)33.14B
Shares Out5.88M
EPS (ttm)5,635.88
PE Ratio5.84
Forward PE5.77
Dividend900.00 (2.74%)
Ex-Dividend DateDec 27, 2024
Volume18,008
Average Volume25,248
Open33,450
Previous Close33,650
Day's Range33,100 - 33,800
52-Week Range23,750 - 33,950
Beta0.21
RSI63.49
Earnings DateAug 13, 2025

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2024, Daihan Pharmaceutical's revenue was 204.19 billion, an increase of 4.23% compared to the previous year's 195.91 billion. Earnings were 33.76 billion, an increase of 18.76%.

Financial Statements

News

There is no news available yet.